Achim Newrzella, Ph.D.

Achim joined the Results Healthcare team in 2015. Achim has a BSc in biochemistry from the University of Birmingham and completed a Ph.D. looking at the identification and culture of prostate cancer stem cells from University College London. He also spent a brief period at Bayer Healthcare, working on process development and optimization in biologics manufacturing. Since joining Results, he has worked on a variety of transactions across the healthcare sector, including the sale of Leukine® by Sanofi to Partner Therapeutics, the acquisition of Kent Pharmaceuticals by Duke Street Capital, SK Biotek’s acquisition of BMS’ Swords manufacturing, and investment by SEP in Dotmatics.